https://orcid.org/0000-0002-4050-3193
References
- American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41:S13–S27.
- Barbour LA. New concepts in insulin resistance of pregnancy and gestational diabetes: long-term implications for mother and offspring. J Obstet Gynaecol. 2003;23(5):545–549.
- Moyer VA. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(6):414–420.
- Fasshauer M, Blüher M, Stumvoll M. Adipokines in gestational diabetes. Lancet Diabetes Endocrinol. 2014;2(6):488–499.
- Al-Badri MR, Zantout MS, Azar ST. The role of adipokines in gestational diabetes mellitus. Ther Adv Endocrinol Metab. 2015;6(3):103–108.
- Lappas M, Yee K, Permezel M, et al. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol. 2005;186(3):457–465.
- Silswal N, Singh AK, Aruna B, et al. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005;334(4):1092–1101.
- Bokarewa M, Nagaev I, Dahlberg L, et al. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174(9):5789–5795.
- Hu SM, Chen MS, Tan HZ. Maternal serum level of resistin is associated with risk for gestational diabetes mellitus: a meta-analysis. World J Clin Cases. 2019;7(5):585–599.
- Mamali I, Roupas ND, Armeni AK, et al. Measurement of salivary resistin, visfatin and adiponectin levels. Peptides. 2012;33(1):120–124.
- Yin J, Gao H, Yang J, et al. Measurement of salivary resistin level in patients with type 2 diabetes. Int J Endocrinol. 2012; 2012:359724
- Srinivasan M, Meadows ML, Maxwell L. Assessment of salivary adipokines resistin, visfatin, and ghrelin as type 2 diabetes mellitus biomarkers. Biochem Res Int. 2018;2018:7463796
- Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–682.
- Janardhanam B, Zunt S, Srinivasan M. Quality assessment of saliva bank samples. Biopreserv Biobank. 2012;10(3):282–287.
- Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307–312.
- Fan H-Q, Gu N, Liu F, et al. Prolonged exposure to resistin inhibits glucose uptake in rat skeletal muscles. Acta Pharmacol Sin. 2007;28(3):410–416.
- Dunmore SJ, Brown JE. The role of adipokines in β-cell failure of type 2 diabetes. J Endocrinol. 2013;216(1):T37–T45.
- Zhou Y, Zhang M, Guo W, et al. Expression of resistin protein in normal human subcutaneous adipose tissue and pregnant women subcutaneous adipose tissue and placenta. J Huazhong Univ Sci Technolog Med Sci. 2006;26:288–291.
- Siddiqui K, George TP, Nawaz SS, Shehata N, et al. Serum adipokines (adiponectin and resistin) correlation in developing gestational diabetes mellitus: pilot study. Gynecol Endocrinol. 2018;34(6):502–506.
- Boyadzhieva M, Atanasova I, Zacharieva S, et al. Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls. J Endocrinol Invest. 2013;36:944–949.
- Desai GS, Mathews ST. Saliva as a non-invasive diagnostic tool for inflammation and insulin-resistance. World J Diabetes. 2014;5(6):730–738.
- Esser D, Alvarez–Llamas G, de Vries MP, et al. Sample stability and protein composition of saliva: implications for its use as a diagnostic fluid. Biomark Insights. 2008;3:25–27.
- Okten SB, Bildacı TB. Salivary Leptin and Chemerin; a novel way of gestational diabetes screening. Gynecol Endocrinol. 2020; Apr 10:1–3.
- Shimada M, Seki H, Samejima M, et al. Salivary melatonin levels and sleep-wake rhythms in pregnant women with hypertensive and glucose metabolic disorders: a prospective analysis. BST. 2016;10(1):34–41.
- Zamani-Ahari U, Zamani-Ahari S, Fardi-Azar Z, et al. Comparison of total antioxidant capacity of saliva in women with gestational diabetes mellitus and non-diabetic pregnant women. J Clin Exp Dent. 2017;9(11):e1282–e86.